Obesity-associated reductions in IL-33 expression in VAT impair the function of Tregs and dysregulate the immune response, leading to an increased susceptibility to developing T2DM [330]. The gene discussed is IL33; the disease is obesity due to melanocortin 4 receptor deficiency.